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The diuretic agents bumetanide, xipamide, indapamide, and related compounds were inves-
tigated in order to determine the effect of different ionization sites on their collisionally
activated dissociation and the corresponding fragmentation pathways. Therefore, analytes
were selectively alkylated, and structural analogues as well as deuterium labeled compounds
synthesized, which contain a reduced number of ionizable hydrogen atoms. Thus, specific
hydrogen abstractions and their correlated dissociation routes of the negatively charged
molecules were eliminated, providing evidence for the influence of the location of ionization
on product ion spectra. Fragment ions such as m/z 78 indicate ionization at the commonly
present sulfamoyl residue of diuretics but does not exclude additional ionization sites. Product
ion spectra of the investigated diuretic agents proved to be composed by fragmentations
initiated from different hydrogen abstractions. Moreover, the generation of radical anions by
collision-activated dissociation of even-electron precursor ions was observed, the generation of
which is discussed by proposed fragmentation pathways. (J Am Soc Mass Spectrom 2003, 14,
658–670) © 2003 American Society for Mass Spectrometry
Since the use of electrospray ionization interfacedto tandem mass spectrometry has proven to be apowerful tool of identification of drugs and their
metabolites [1], the interpretation of mass spectra ob-
tained by collisionally activated dissociation and the
corresponding fragmentation patterns has become even
more important. The knowledge of origin and assumed
structure of fragment ions provides important informa-
tion about the administered drug and its modifications,
which is essential for different analytical laboratories,
e.g., for those performing anti-doping, clinical, or foren-
sic analyses. Modifications of drugs such as diuretics
can be caused by metabolism [2–6] or by intentional
alterations of the molecules prior to administration in
order to characterize the influence of functional groups
on the efficiency of the particular remedy [7–10]. For
instance, the diuretic effect of chlorothiazide (6-chloro-
7-sulfamoyl-1,2,4-benzothiadiazine-1,1-dioxide) was in-
creased by a factor of 10 by the hydration of its N-3¢C-4
double bond to hydrochlorothiazide (6-chloro-7-sulfa-
moyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide)
[11–13], and the substitution of a 2,6-dimethylanilide
residue by a 2,6-dimethylpiperidyl group and a hy-
droxyl group by a hydrogen changes the diuretic agent
xipamide to clopamide (Figure 1). The identification of
structural deviations can be accomplished by means of
different ionization techniques such as electron impact
ionization (EI) [14–16] or electrospray ionization (ESI)
[17–19], followed by MS-MS experiments with efficient
collision-activated dissociation (CAD), generating
structure informative fragment ions of the analytes.
With negative electrospray ionization, the location of
hydrogen abstraction has a significant influence on the
subsequent dissociation of the deprotonated molecule,
and thus on the fragmentation pattern, which provides
fundamental information about the molecule. In gen-
eral, fragmentation of charged molecules generated by
protonation or deprotonation of analytes can undergo
charge-driven and/or charge-remote fragmentations.
The latter one requires a considerable activation, e.g., by
CAD, as the soft ionization by means of ESI rarely
introduces sufficient energy to initiate rearrangements
followed by molecule dissociation [20]. Charge-remote
fragmentation in particular provides detailed and spe-
cific information on molecule structures as demon-
strated in the literature for several classes of com-
pounds [21–23].
In the present study, we investigated the effect of
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structural modifications of diuretics on their collision-
activated dissociation behavior, analyzed by negative
electrospray ionization and tandem mass spectrometry.
The presence of acidic groups such as carboxyl func-
tions are preferred ionization sites, initiating deter-
mined fragmentation routes of the negatively charged
molecule [24, 25]. The derivatization of those function-
alities to methyl esters, for instance, entails the prefer-
ence of other, formerly less acidic hydrogens to be
abstracted from the analyte being responsible for the
generation of its anion and causing a different dissoci-
ation scheme. With diuretics, sulfamoyl residues are
also frequently observed, which are targets of negative
ionization as well as amide groups of several substrates.
By means of selective derivatization, synthesis of la-
beled or modified analogues of the analytes and tandem
mass spectrometry, fragmentation patterns of diuretics
related to bumetanide, xipamide and indapamide were
studied.
Experimental
Chemicals
Benzoyl chloride (99%), 3-chlorobenzoic acid (99%),
3-chloro-4-sulfamoylbenzoic acid (98%), 3-chloro-4-sul-
famoylbenzoyl chloride (99%), 3-chloroaniline (99%),
2,3,4,5,6-pentadeuteroaniline, 2,4,6-trimethylaniline
(98%), phenylhydrazine (97%), and phosphorus trichlo-
ride (99%) were purchased from Aldrich (Steinheim,
Germany). N'-methyl-N'-phenylhydrazine (95%), chlo-
robenzene (puriss.), triethylamine (purum), and thionyl
chloride (purum) were obtained from Fluka (Buchs,
Switzerland). Trimethylchlorosilane (TMCS) was sup-
plied by Macherey-Nagel (Du¨ren, Germany) and dis-
tilled before use. Diethyl ether (dried) and iodomethane
(for synthesis) were from Merck (Darmstadt, Germany),
and potassium carbonate (p.a.) was from Riedel-de
Haen (Seelze, Germany).
Figure 1. Structure formulae of diuretics and synthesized analogues: 1 bumetanide; 2 piretanide; 3
furosemide; 4 4-chloro-3-sulfamoylbenzoic acid; 5 xipamide; 6 N-(4-chloro-3-sulfamoylbenzoyl)-2,4,6-
trimethylaniline; 7 N-(4-chloro-3-sulfamoylbenzoyl)-3-chloraniline; 8 N-(4-chloro-3-sulfamoylben-
zoyl)-2,3,4,5,6-pentadeuteroaniline; 9 indapamide; 10 clopamide; 11 N-(4-chloro-3-sulfamoylbenzoyl-
N'-phenylhydrazine; 12 N-(4-chloro-benzoyl)-N'-phenylhydrazine; 13 N-benzoyl-N'-phenylhydrazine.
R  CH3 or R  H.
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Diuretics
Xipamide (Aquaphor 10) was obtained from Beiersdorf
(Hamburg, Germany), and Indapamide-hemihydrate
(Natrilix) from Pharmacodex (Mu¨nchen, Germany). Bu-
metanide was purchased from Dr. Karl Thomae GmbH
(Biberach, Germany). Piretanide was supplied by Cas-
sella-Riedel Pharma (Frankfurt, Germany), Clopamide
(Brinaldix) by Sandoz (Nu¨rnberg, Germany) and Furo-
semide was from Hoechst (Frankfurt, Germany).
Site-Specific Methylation of Diuretics and Related
Compounds
Methylation of carboxyl groups without alkylation of
primary amino groups or amide functions was accom-
plished by treating the substrate with anhydrous hy-
drogen chloride in methanol (HCl/MeOH) [26]. Briefly,
a total amount of 0.1 mmol of the particular compound
was dissolved in 10 mL of 1 M HCl/MeOH and
incubated at 50 °C. After 3 h, the solution was evapo-
rated to dryness and the residue resuspended in 10 mL
of methanol. HCl/MeOH was prepared by the addition
of 100 mmol trimethylchlorosilane (TMCS) to 100 mL of
freshly distilled methanol under constant stirring for 5
min.
Methylation of carboxyl and sulfamoyl groups was
performed by means of iodomethane in the presence of
a base [27]. Here, 0.1 mmol of substrate were dissolved
in 10 mL of acetonitrile, 2 mmol of potassium carbonate
and 200 l of iodomethane were added and the mixture
was heated at 50 °C under constant stirring. After 3 h,
the reaction mixture was poured through a medium
porosity frit, and the solution was evaporated to dry-
ness, yielding the methylated compound.
Hydrolysis of the resulting methyl ester was
achieved by incubation of the substrate in a mixture of
methanol and 0.5 M aqueous sodium hydroxide (9:1,
vol:vol) at room temperature for one h. The solution
was evaporated to dryness, the dry residue resus-
pended in water and the reaction product was purified
by solid-phase extraction on PAD-I polystyrene resin.
Employing this method, the m-sulfamoylbenzoic acid
derivatives (Group 1, vide infra) are obtained bearing
N,N-dimethylsulfamoyl functions.
Synthesis of Structural Analogues to Xipamide
and Indapamide
The synthesis of xipamide analogues was accomplished
by the reaction of equal amounts (1.3 mmol) of 3-chloro-
4-sulfamoylbenzoic acid and 2,4,6-trimethylaniline,
3-chloroaniline or 2,3,4,5,6-pentadeuteroaniline sus-
pended in 6 mL of chlorobenzene in the presence of 60
L phosphorus trichloride. The mixture was incubated
at 100 °C for 14 h, filtered through a medium-porosity
frit and the desired product precipitated from the
cooled filtrate [28].
In order to synthesize compounds analogous to
indapamide, 10 mmol of phenylhydrazine or N'-
methyl-N'-phenylhydrazine and 15 mmol of triethyl-
amine were solved in 20 mL of diethyl ether, and the
solution was added to 10 mmol of benzoyl chloride or
its appropriate derivatives (such as 3-chlorobenzoyl
chloride, 3-chloro-4-sulfamoylbenzoyl chloride, and
N,N-dimethyl-3-chloro-4-sulfamoylbenzoyl chloride) in
50 mL of diethyl ether [29]. The reaction mixture was
stirred at room temperature for 14 h, the triethylamine
salts were removed by filtration, and the desired com-
pound was obtained by evaporation of the organic
solvent.
The reagents 3-chlorobenzoyl chloride, 3-chloro-4-
sulfamoylbenzoyl chloride and N,N-dimethyl-3-chloro-
4-sulfamoylbenzoyl chloride were prepared by treating
2.28 mmol of their corresponding acids with 3.7 mmol
of thionyl chloride at 60 °C for 4 h. The solution was
stored at room temperature for 12 h, evaporated to
dryness, and the resulting product was kept in a
vacuum desiccator over phosporus pentoxide for 4 h
before usage.
Purity and Characterization of Synthesized
Compounds
Purities of synthesized compounds were tested by high
performance liquid chromatography (HPLC) on a
Hewlett-Packard 1090 Series II instrument equipped
with a UV detector. The column used was a Macherey-
Nagel (Du¨ren, Germany) Nucleosil 120-5 C18 with the
eluent A: distilled water, and eluent B: acetonitrile. The
flow was set to 1 mL/min, and a gradient was used
from 10% B to 90% B in 10 min. The analytes were
dissolved in methanol at concentrations of 20 g/mL,
and 10 L were injected into the HPLC-UV system.
Purities varied from 37 to 95%, and with compounds of
a purity less than 70%, fractions of eluting substances
were collected and the isolated compounds of interest
were analyzed subsequently by mass spectrometry.
Impurities were identified by LC-ESI-MS and ESI-
MS/MS analysis primarily as starting materials, which
did not interfere with the following MS/MS experi-
ments of target compounds. Additional structure con-
firmation of synthesized material was accomplished by
nuclear magnetic resonance spectroscopy (NMR) utiliz-
ing a Bruker DRX 500 instrument. The substances were
dissolved in CD3OD or deuterated dimethyl sulfoxide
(DMSO) and analyzed with different experiments, such
as 1H, 13C/DEPT (Distortionless Enhancement by Po-
larization Transfer), H,H-COSY (Homonuclear Corre-
lated Spectroscopy), HMQC (Heteronuclear Multiple
Quantum Correlation), NOESY (Nuclear Overhauser
Effect Spectroscopy), and ROESY (Rotating Frame Nu-
clear Overhauser Effect Spectroscopy), at 25 °C. As all
syntheses were performed according to comparable
procedures and well established chemical reactions,
NMR characterization was done only for five represen-
tative substances as listed in Table 1.
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Mass Spectrometry
All MS/MS analyses were performed on a PE Sciex API
2000 triple quadrupole mass spectrometer (Foster City,
CA), while MSn experiments were done with an Agilent
1100 Series LC/MSD Trap SL (Waldbronn, Germany).
Each instrument was equipped with an electrospray
interface. The flow rate of the solution containing the
analyte was 10 L/min, introduced by a syringe pump
into the ESI interface. All analytes were dissolved in a
mixture of acetonitrile/water (1:1, vol:vol) with a con-
centration of 5 g/mL. The ionization mode was neg-
ative and variable parameters such as declustering and
focusing potentials of the triple quadrupole mass spec-
trometer or skimmer and capillary exit voltage of the
Agilent LC/MSD were optimized for maximum
abundance of the ions of interest (M  H). For the
API 2000, the collision gas was nitrogen delivered by
a Whatman 75–72 nitrogen generator, and a constant
pressure of 1.8e-5 torr was applied to the collision cell
in MS/MS experiments. The collision offset voltage
for product ion scans was varied from 15–35 eV, as
indicated in Tables 2, 3, and 4. The source tempera-
ture was 30 °C, the ion spray voltage set to -5500 V,
and nitrogen was utilized as nebulizing gas at a
pressure of 20 psi.
The Ion trap was operated with helium as damping
gas, and nitrogen was used as nebulizing gas for ESI.
MS3 and MS4 experiments were performed at 30 °C in
order to qualitatively determine product ions of frag-
ments observed in MS/MS spectra. Thus, precursor
ions were manually selected from MS/MS experiments
(4 Da window) and subsequently dissociated by reso-
nant activation at variable fragmentor voltages (band
width 10 Da) in order to substantiate proposed frag-
mentation routes.
Results and Discussion
Common structure characteristics of numerous diuret-
ics such as 3-sulfamoylbenzoic acid derivatives [Group
1, e.g., bumetanide (1), piretanide (2), and furosemide
(3)], N-(4-chloro-3-sulfamoylbenzoyl)aniline deriva-
tives [Group 2, e.g., xipamide (5)], 4-chloro-3-sulfa-
moylbenzamide derivatives [Group 3, e.g., indapamide
(9) and clopamide (10)], and the entire class of thiazide-
based diuretics, are a benzene ring structure, bearing a
sulfamoyl residue ortho-located to an electronegative
substitute such as a chlorine atom or phenoxy group
(Figure 1). Owing to these analogies, comparable neg-
ative ionization and subsequent CAD behaviors are
observed within and also between the groups men-
tioned above, giving rise to mass spectra with common
elimination reactions and fragment ions that are pro-
posed to be generated by charge-driven as well as
Table 1. 13C chemical shifts (ppm) of synthesized compounds. All substances were dissolved in CD3OD
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Table 2. Relative abundances of common and individual product ions of substances based on 3-sulfamoylbenzoic acid
Nr Compound
Common product ions m/z
Individual product ions m/z
CGP
(10e-5 torr)a
CE
(eV)b (M-H) (M-H-CO2)
 (M-H-HCl-CO2)
 (M-H-CO2-SO2)
 80 78
1 Bumetanide 1.8 25 363 (70) 319 (15) - 255 (1) 100 - 306 (3) 271 (3) 262 (3) 238 (8) 207 (40)
1.1 Bumetanide methyl ester 1.8 30 377 (65) - - - - - 320 (9) 285 (2) 256 (4) 237 (5) 221 (100)
2 Piretanide 1.8 25 361 (63) 317 (15) - 253 (1) 100 - - 269 (2) 225 (2) 205 (33)
2.1 Piretanide methyl ester 1.8 30 375 (33) - - - - - 316 (3) 235 (4) - - 219 (100)
3 Furosemide 1.8 25 329 (6) 285 (83) 249 (3) - - 4 205 (100) 126 (1) - - -
4 4-Chloro-3-sulfamoyl benzoic acid 1.8 15 234 (35) 190 (100) 154 (1) 126 (1) 4 - 91 (1) - - - -
4.1 4-Chloro-3-sulfamoyl benzoic acid
methyl ester
1.8 25 248 (32) - - - - 100 212 (65) 184 (26) 153 (41) 148 (22) 89 (15)
4.2 4-Chloro-3-N,N-dimethylsulfamoyl
benzoic acid
1.8 20 262 (12) 218 (100) - - - - 175 (10) 126 (4) 111 (4) 108 (35) 91 (3)
aCGP  collision gas pressure.
bCE  collision energy.
Table 3. Relative abundances of common and individual product ions of substances based on N-(4-chloro-3-sulfamoyl benzoyl)aniline
Nr Compound
Common product ions m/z
Individual product ions m/z
CGP
(10e-5 torr)a
CE
(eV)b (M-H) (M-H-HCl) (M-H-SO2)
 80 78
5 Xipamide 1.8 35 353 (100) - - - 77 274 (96) 273 (50) 206 (14) 196 (9) 170 (16) 127 (47)
6 N-(4-Chloro-3-sulfamoylbenzoyl)-
2,4,6-trimethylaniline
1.8 30 351 (25) 315 (10) 287 (6) 20 5 269 (3) - 190 (100) 160 (6) 154 (9) 90 (3)
6.1 N-(4-Chloro-3-N,N-
dimethylsulfamoylbenzoyl)-2,4,6-
trimethylaniline
1.8 30 379 (43) - - - - 361 (3) 271 (9) 218 (100) 175 (23) 174 (15) 108 (52)
7 N-(4-Chloro-3-sulfamoylbenzoyl)-
3-chloroaniline
1.8 35 343 (22) 307 (8) 279 (10) 77 54 264 (5) 259 (9) 190 (100) - 154 (42) 90 (24)
8 N-(4-Chloro-3-sulfamoylbenzoyl)-
2,3,4,5,6-pentadeuteroaniline
1.8 30 314 (38) 278 (18) 250 (21) 32 26 - 230 (8) 190 (100) - 154 (32) 90 (14)
aCGP  collision gas pressure.
bCE  collision energy.
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Table 4. Relative abundances of common and individual product ions of substances based on 4-chloro-3-sulfaoylbenzamide
Nr Compound
common product ions m/z
Individual product ions m/z
CGP
(10e-5 torr)a
CE
(eV)b (M-H) (M-CH3)

(M-H-
HCl)
(M-H-
SO2)
 80 78
9 Indapamide 1.8 30 364 (36) - - - 4 4 233 (11) 216 (13) 190 (7) 189 (100) - 132 (19) 126 (1) 105 (5) - -
10 Clopamide 1.8 30 344 (100) - 308 (8) 280 (10) 2 38 231 (9) 216 (7) 190 (13) 189 (23) 167 (44) 132 (6) 126 (1) 105 (1) - -
11 N-(4-Chloro-3-
sulfamoylbenzoyl)-
N'-methyl-N'-
phenylhydrazine
1.8 30 338 (45) 323 (24) - - 4 14 223 (7) 216 (6) - 189 (100) - 132 (20) - 105 (4) - -
11.1 N-(4-Chloro-3-N,N-
dimethylsulfamoyl-
benzoyl)-N'-
methyl-N'-
phenylhydrazine
1.8 30 366 (100) 351 (73) - - - - 258 (16) 216 (20) - - 152 (19) 147 (4) 126 (4) 106 (10) 93 (11) -
11.2 N-(4-Chloro-3-
sulfamoylbenzoyl)-
N'-phenylhydrazine
1.8 30 324 (45) - 288 (1) 260 (1) 12 22 - 216 (15) 190 (84) 189 (87) 133 (58) 132 (37) 126 (9) 105 (100) 92 (2) 77 (54)
11.3 N-(4-Chloro-3-N,N-
dimethylsulfamoyl-
benzoyl)-N'-
phenylhydrazine
1.8 30 352 (67) - - - - - 244 (23) 216 (7) 208 (25) 152 (7) 133 (86) - 108 (5) 105 (100) 92 (4) 77 (39)
12 N-4-Chlorobenzoyl-
N'-methyl-N'-
phenylhydrazine
1.8 25 259 (32) 244 (100) 223 (5) - - - - - - - - - - 106 (5) 93 (4) -
12.1 N-4-Chlorobenzoyl-
N'-phenylhydrazine
1.8 25 245 (92) - 209 (13) - - - 227 (3) - - - 133 (76) - - 105 (100) 92 (14) 77 (69)
13 N-Benzoyl-N'-
methyl-N'-
phenylhydrazine
1.8 25 225 (29) 210 (100) - - - - - - - - - - 126 (8) 106 (6) 93 (4) -
13.1 N-Benzoyl-N'-
phenylhydrazine
1.8 25 211 (65) - - - - - 193 (10) - - - 133 (38) - - 105 (55) 92 (34) 77 (53)
aCGP  collision gas pressure
bCE  collision energy
charge-remote fragmentation. Derivatization of these
molecules in terms of ionizable hydrogens leads to
significant changes of their fragmentation patterns,
which enable the identification of position and charac-
ter of modification. In terms of that, knowledge about
origin and possible generation of individual and infor-
mative fragment ions is necessary. Thus, diuretics of
closely related structures as well as compounds compa-
rable to these diuretics, synthesized with selected mod-
ifications were analyzed, providing detailed informa-
tion about ionization sites and the subsequent
dissociation after collisional activation of the analytes.
Group 1—3-sulfamoylbenzoic acid derivatives
(Figure 1, 1–4)
Figure 2a shows the product ion spectrum of m/z 363 of
bumetanide (3-butylamino-4-phenoxy-5-sulfamoylben-
zoic acid, 1), the structure of which comprises three
likely locations of hydrogen abstraction with a carboxyl
function, a secondary amino and a sulfamoyl group.
The first-mentioned bears the most acidic hydrogen,
and thus the ionization at this position is preferred over
the other possibilities. The most abundant fragment ion
at a collision energy of 25 eV was m/z 80, the composi-
tion of which is proposed to be [SO2NH2]
 of the
sulfamoyl side chain. The generation of this ion requires
the presence of a sulfamoyl group comprising two
hydrogens, which indicates ionization remote from this
residue, and thus the mechanism of charge-remote
fragmentation. Evidence for this postulation was ob-
tained by the analysis of the structurally related
4-chloro-3-sulfamoylbenzoic acid (Figure 1, 4) under
different derivatization conditions. The product ion
spectrum of its deprotonated molecule, with identical
collision gas pressure as chosen for Compound 1, also
contains the fragment ion at m/z 80 (Table 2). With the
methylation of the carboxyl group (Compound 4.1), an
ionization of the resulting molecule is possible solely at
the sulfamoyl residue. As a consequence, the ion at m/z
80 disappeared, and an intense fragment ion at m/z 78
with a composition of [SO2N]
 (Table 2) was generated,
supposably by charge-driven dissociation. The product
ion spectrum obtained after selective N,N-dimethyla-
tion of the sulfamoyl group (Compound 4.2) confirms
the findings, as the ion at m/z 80 (of the underivatized
Compound 4) shifts to m/z 108, owing to the substitu-
tion of two hydrogens by methyl groups (Table 2). The
methylation of the carboxyl group of 1 gives rise to the
product ion spectrum shown in Figure 2b, where the
Figure 2. (a) ESI product ion spectrum of m/z 363 of bumetanide (1), CE  25 eV, collision gas
pressure  1.8e-5 torr; (b) ESI product ion spectrum of m/z 378 of bumetanide methyl ester (1.1), CE
 30 eV, collision gas pressure  1.8e-5 torr; (c) ESI product ion spectrum of m/z 361 of piretanide (2),
CE  25 eV, collision gas pressure  1.8e-5 torr; (d) ESI product ion spectrum of m/z 375 of piretanide
methyl ester (2.1), CE  30 eV, collision gas pressure  1.8e-5 torr.
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fragment ion at m/z 80 is eliminated entirely. The
compound piretanide (Figure 1, 2) dissociates with a
fragmentation pattern comparable to that of underivat-
ized Compound 1 (Figure 2c), with significant ions
differing by 2 Da owing to the exchange of a bu-
tylamino residue by a pyrrolidinyl group. Principal
eliminations besides the sulfamoyl residue of both
native analytes, 1 and 2, are neutral losses of carbon
dioxide (44 Da), sulfur dioxide (64 Da), and the
elements of C6H4O (92 Da, presumably the phenoxy
group under migration of one hydrogen), generating
their characteristic product ion spectra. Proposed frag-
mentation schemes for the described dissociation pro-
cesses are shown in Scheme 1a. In addition, Compound
1 releases its butyl residue (57) by a homologous
fission of the carbon-nitrogen bond, giving rise to the
low abundant radical anion at m/z 306, and, consecu-
tively, to the fragment at m/z 262 after loss of carbon
dioxide (Scheme 1a). This particular fragmentation is
not observed in the spectrum of 2 (Figure 2c), as the
corresponding pyrrolidinyl residue would require the
rearrangement of two single bonds under a process of
ring-opening followed by the release of a C4H7 radical.
Another example for a diuretic agent based on the
generic structure of 3-sulfamoylbenzoic acid is furo-
semide (Figure 1, 3). Instead of a 5-positioned pyrrolidi-
Scheme 1. (a) Postulated fragmentation of 1; (b) proposed fragmentation route of 3.
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nyl or butylamino residue as present in the molecules of
2 or 1, respectively, furosemide bears a furfurylamino
group, which is in the 6-position and thus located ortho
to the carboxyl function. Additionally, the para phe-
noxy group is replaced by a chlorine atom. As a
consequence, Compound 3 is closely related to
4-chloro-3-sulfamoylbenzoic acid (4), but its product
ion spectrum of the deprotonated molecule m/z 329
differs significantly from 4. Compound 3 does not give
rise to the intense product ion at m/z 80 as found with 4,
but a fragment at m/z 78 of low abundance (Table 2).
According to the data discussed above, this fact indi-
cates a preferred ionization at the sulfamoyl residue
and not at the carboxyl group, owing presumably to
presence of a strong hydrogen bond with the secondary
amino group present at position 6. The entire fragmen-
tation pattern of 3 is consistent with a hydrogen abstrac-
tion at the sulfamoyl residue followed by subsequent
eliminations of CO2 (44 Da to m/z 285), C5H4O of the
furfuryl group (80 Da to m/z 205) and SO2NH (79 Da
to m/z 126) as proposed in Scheme 1b. Here also, both
charge-driven and charge-remote fragmentations are
observed. While CO2 and the furfuryl group are ex-
pelled remote from the assumed ionization site, m/z 78
and 126 are generated under conditions of a charge-
driven dissociation. The intermediately generated frag-
ment ion m/z 205 and its degradation products m/z 126
and 78 (as proven with MS3 experiments) are also
postulated for the dissociation of thiazidic diuretics as
described elsewhere [15].
Group 2—N-(4-chloro-3-sulfamoyl benzoyl)aniline
Derivatives (Figure 1, 5–8)
A representative compound of Group 2 is the diuretic
agent xipamide (4-chloro-3-sulfamoylsalicoyl-2'-6'-dim-
ethylanilide, Figure 1, 5). It contains three eligible
ionization sites including the sulfamoyl residue, the
phenolic hydroxyl group at position 6 and the hydro-
gen of the anilide function. In Figure 3a, the product ion
spectrum of the deprotonated molecule m/z 353 of 5 is
shown, which comprises an intense fragment at m/z 78,
but no ion at m/z 80. Considering this indicator only, the
hydrogen abstraction at the SO2NH2 residue appears
to be preferred over the other available ionization sites,
but analyses of the synthesized analogues 6, 7, and 8
(Figure 1) provide evidence for a CAD mass spectrum
of Compound 5, which is composed by fragment ions
generated by the ionization of different functional
groups. The fragments at m/z 274 and 273 are resulting
from the neutral loss of SO2NH (79 Da) and the
elimination of the radical SO2NH2 (80 Da), respec-
tively, both of which are generated by charge-remote
fragmentation from a molecule ionized at the phenolic
hydroxyl group. This postulation is based on the prod-
uct ion spectrum of m/z 351 of Compound 6 (Figure 3b),
that comprises a 2,4,6-trimethylanilide group but lacks
the phenolic hydroxyl function. Here, the counterparts
tom/z 274 and 273 of 5 are absent (Table 3), because the
ionization site required for their generation is missing.
In addition, Compound 5's preferred release of the
uncharged sulfonamide residue, either by neutral loss
(SO2NH) or by homologous fission of the S™C bond
between the sulfamoyl residue and the phenolic ring
structure (SO2NH2
•), explains the absence of its charged
species at m/z 80. By way of contrast, the ions corre-
sponding to m/z 206 and 170 are observed in the
spectrum of Compound 6 at m/z 190 and 154, respec-
tively (Table 3). Thus, their genesis is proposed to be
charge-driven, initiated by the ionization at the amide
function as demonstrated in Scheme 2. As the fragment
m/z 206 of 5 (or m/z 190 of Compound 6) comprises the
chloro-sulfamoylphenol nucleus, a subsequent elimina-
tion of HCl (36 Da) to m/z 170 (or m/z 154 of Com-
pound 6) was taken into consideration, but MS3 exper-
iments excluded this fragmentation pathway. But by
means of further studies with Compound 6, the initial
loss of HCl from the deprotonated molecule to m/z 315
was observed, giving rise to the secondary fragment ion
at m/z 154, corresponding to m/z 170 of 5. Further
evidence for the location of hydrogen abstraction at the
amide group in case of the genesis of m/z 206 and 190
was obtained by selective methylation of the sulfamoyl
residue of Compound 6 (Table 3, 6.1). Here, the nega-
Figure 3. (a) ESI product ion spectrum of m/z 353 of xipamide (5),
CE  35 eV, collision gas pressure  1.8e-5 torr; (b) ESI product
ion spectrum of m/z 351 of N-(4-chloro-3-sulfamoylbenzoyl)-2,4,6-
trimethylaniline (6), CE  30 eV, collision gas pressure  1.8e-5
torr.
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tive ionization was limited to the predicted functional
group, and the ion corresponding to m/z 190 (and thus
to m/z 206 of Compound 5) was observed at m/z 218,
according to the Biemann shift rule by the substitution
of two hydrogens by CH3 residues, proving the ioniza-
tion at the amide function. However, the counterpart to
m/z 154 was not detected, which indicates the necessity of
the mobile nitrogen-bound hydrogens for the elimination
of hydrochloric acid from the deprotonated molecule. The
presence of m/z 80 in the product ion spectrum of
Compound 6 also indicates ionization different from
the sulfonamide group, and in addition, its selective
methylation (6.1) yields an intense fragment at m/z 108
(m/z 80  28 Da). By contrast, the ion atm/z 106, the
counterpart to m/z 78, was not detected (Table 3).
The analysis of the synthesized analogue Compound
7 confirmed the described ionization and dissociation
properties by basically identical gas-phase behaviors
with Compounds 5 and 6 (Table 3). The presence of a
3-chlorophenyl residue instead of 2,4,6-trimethylphenyl
or 2,6-dimethylphenyl anilide did not influence the
fragmentation route, and the substitution by a 2,3,4,5,6-
pentadeuterophenyl residue (Compound 8) also sup-
ported the interpretation of ionizations remote from the
anilidic phenol group. No evidence for the participation
of deuteria in elimination or ionization processes was
observed.
Group 3—4-Chloro-3-Sulfamoyl Benzamide
Derivatives (Figure 1, 9–13)
This group includes the diuretics clopamide (1-(4-
chloro-3-sulfamoylbenzamido)-2,6-dimethylpiperidine,
Figure 1, 10) and indapamide (N-(4-chloro-3-sulfamoyl-
benzamido)-2-methylindoline, Figure 1, 9), the latter
one of which will be discussed in detail. In Figure 4a,
the product ion scan of the deprotonated molecule of 9
m/z 364 is shown, which comprises ions at m/z 233, 216,
189, 80, and 78, for instance. The molecule of indapam-
ide contains two ionization sites with the sulfamoyl
residue and the amide functionality. Considering the
presence of m/z 78 and 80, a fragmentation initialized by
hydrogen abstraction at both groups is possible, the
effects of which were investigated in terms of subse-
quent collision-activated dissociation. In order to com-
pare the spectrum of Compound 9 (Figure 4a) with
those obtained after selective modification of functional
groups, removal and addition of particular pieces of the
molecule, the Compounds 11, 12, and 13 (Figure 1) were
Scheme 2. Proposed fragmentation pattern of 5 and analogues.
Figure 4. (a) ESI product ion spectrum of m/z 364 of indapamide
(9), CE  30 eV, collision gas pressure  1.8e-5 torr; (b) ESI
product ion spectrum of m/z 338 of N-(4-chloro-3-sulfamoylben-
zoyl)-N'-methyl-N'-phenylhydrazine (11), CE  30 eV, collision
gas pressure  1.8e-5 torr.
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synthesized and analyzed under comparable conditions
as 9 (Table 4). The product ion spectrum of Compound
11 is shown in Figure 4b containing identical fragment
ions as 9 except for m/z 223 and 323. The latter ion
results from an elimination of a methyl radical at the
methylanilide residue, the counterpart of which was not
detectable with indapamide as the particular nitrogen
was part of the indoline structure.
The ion at m/z 233 of Compound 9 is proposed to be
generated by an ionization at the amide group and
subsequent neutral loss of the 2-methylindoline group
accompanied by a hydrogen migration as postulated in
Scheme 3. Indication for this proposal was obtained by
a CAD mass spectrum of m/z 233, which gave rise to the
fragment ions m/z 190 after loss of HNCO, iminometh-
anone, (43 Da) and m/z 126 after consecutive elimina-
tion of sulfur dioxide, (64 Da). Furthermore, it con-
tained the fragment m/z 80, originating from a
sulfamoyl residue without deprotonation.
For the generation of the fragment m/z 189 of Com-
pound 9, ionization at the sulfamoyl function is postu-
lated followed by a homologous fission of the C™C bond
between the 4-chloro-3-sulfamoylphenolic structure
and the amide group in accordance to a charge-remote
fragmentation (Scheme 3). With Compound 5 and its
analogues of Group 2 (Compound 6 and 7), the coun-
terpart to m/z 189 was observed at m/z 206 or 190,
respectively, as a result of ionization remote from the
sulfamoyl residue. With indapamide, hydrogen abstrac-
tion occurs intensively at this particular functionality,
yielding immediately m/z 189, as a precursor ion scan
did not give rise to any other intermediate ion. As a
confirmation of composition, the CAD of m/z 189 gen-
erated the fragments m/z 125 after loss of SO2 (64 Da)
andm/z 78 (SO2N
), but no m/z 80 as its production is
depending on an intact sulfamoyl residue. In addition,
the methylation of the sulfamoyl group of Compound
11 (Table 4, 11.1) limited the possibility of negative
ionization to the amide group under the chosen condi-
tions. Thus, m/z 189 or its corresponding ion at m/z 207
(28 Da) were not observed in a product ion spectrum
of m/z 366 (Table 4), proving the necessity of an ioniza-
tion at the sulfamoyl residue for a radicalic release of
the 4-chloro-3-sulfamoylphenol anion.
Compound 12 is the analog of 11 minus the sulfa-
moyl group, the product ion spectrum of which con-
tains mainly the fragments resulting from the elimina-
tion of a methyl radical or HCl (Table 4). Also the CAD
spectrum of Compound 13, which additionally lacks the
chlorine atom at the benzoyl residue, does not yield
more informative ions of the analytes (Table 4). But the
introduction of a new ionization site by substitution of
the nitrogen-bound methyl group by a hydrogen (Table
4, 13.1) enables different fragmentation pathways, giv-
ing rise to the mass spectrum shown in Figure 5a. With
all abundant product ions such as m/z 133, 105, 92 and
77, the negative charge remains remote of the benzoyl
residue as demonstrated with the postulated structures
in Scheme 4. Evidence for the presence of the anilide
group instead of the benzamide functionality was ob-
tained by the analysis of Compound 12.1, also bearing a
hydrogen at the anilide functionality (Table 4). Here,
the chlorine atom at the benzamide residue would shift
the fragment ions by 34 mass units, if they would
comprise this part of the molecule. As shown in Figure
5b, the specified product ions are not affected, which
proves their composition without the 4-chlorobenzoyl
nucleus. With the introduction of a 3-sulfamoyl residue
into Compound 12.1, we obtained Compound 11.2,
which gives rise to the product ion spectrum shown in
Figure 5c. It contains abundant fragments at m/z 133,
105, and 77 as observed already in Compound 13.1, and
additionally intense ions known from Compound 9
such as m/z 216, 190, 189, 126, 80, and 78. Here, a typical
mass spectrum is generated by collision-activated dis-
sociation that comprises fragment ions originating from
Scheme 3. Proposed fragmentation routes of 9.
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different ionization sites and subsequent fragmentation
pathways. Again, selective methylation of the sulfamoyl
function (Table 4, 11.3) eliminates the fragments at m/z 189
and 78, but gives rise to the counterpart of m/z 80 at m/z
108. The ions at m/z 216, 133, 105, and 77 are still present,
indicating their generation independent from an ioniza-
tion of the molecule at the sulfamoyl residue.
Conclusion
The location of ionization plays an important role on
the collision-activated dissociation of compounds based
on the structure of the diuretic agents bumetanide (1),
xipamide (5), and indapamide (9). Indication for ioniza-
tion at the sulfamoyl residue is obtained by the product
ion at m/z 78, but its presence does not exclude neces-
sarily other sites of hydrogen abstraction, as shown for
example with xipamide. Minor or major modifications
of analytes can introduce or eliminate positions of
ionization, and thus severely change and influence
resulting CAD spectra. With these deviations, impor-
tant information about character and also location of
derivatization are provided. In addition, the frequent
generation of radical anions is noteworthy, despite the
commonly accepted “even-electron-rule”. Although the
majority of observed elimination reactions happened in
accordance to this rule, the presence of spacious conju-
gated -electron systems amplifies the homologous
fission of carbon™carbon bonds and the stabilization of
resulting radical anions. This fact should be considered
by interpretations of mass spectra of compounds re-
lated to the analytes investigated in this study.
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